Birmingham Nursing And Rehabilitation Center East | |
733 Mary Vann Lane, Birmingham, Alabama 35215 | |
(205) 854-1361 | |
Name | Birmingham Nursing And Rehabilitation Center East |
---|---|
Location | 733 Mary Vann Lane, Birmingham, Alabama |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 132 |
Occupancy Rate | 71.52% |
Medicare ID (CCN) | 015134 |
Legal Business Name | Birmingham Nursing And Rehabilitation Center East,llc |
Ownership Type | For Profit - Limited Liability Company |
NPI Number | 1922111517 |
Organization Name | BIRMINGHAM NURSING AND REHABILITATION CENTER EAST,LLC |
Address | 733 Mary Vann Ln, Birmingham, AL 35215 |
Phone Number | 205-854-1361 |
News Archive
Boehringer Ingelheim today announced that the New Drug Application (NDA) for its investigational oncology compound afatinib has been accepted for filing and granted Priority Review by the U.S. Food and Drug Administration (FDA).
The Royal Melbourne Hospital has performed the world's first implant of cultured specialist stem cells into an orthopaedic patient who suffered a broken femur nine months ago which failed to heal.
Molecular classification of the four distinct subtypes of gastric cancer could potentially shape tailored treatment options by helping to predict survival outcomes and patients' response to chemotherapy.
In a survey of more than 200 unique hospitals from across the US, nearly half of healthcare organizations (or 47.3 percent) believe their organization is already compliant with federal privacy laws such as ARRA HITECH and HIPAA and is audit ready.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has completed the previously announced acquisition of MemorialCare Health System's laboratory outreach service business.
› Verified 7 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Boehringer Ingelheim today announced that the New Drug Application (NDA) for its investigational oncology compound afatinib has been accepted for filing and granted Priority Review by the U.S. Food and Drug Administration (FDA).
The Royal Melbourne Hospital has performed the world's first implant of cultured specialist stem cells into an orthopaedic patient who suffered a broken femur nine months ago which failed to heal.
Molecular classification of the four distinct subtypes of gastric cancer could potentially shape tailored treatment options by helping to predict survival outcomes and patients' response to chemotherapy.
In a survey of more than 200 unique hospitals from across the US, nearly half of healthcare organizations (or 47.3 percent) believe their organization is already compliant with federal privacy laws such as ARRA HITECH and HIPAA and is audit ready.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has completed the previously announced acquisition of MemorialCare Health System's laboratory outreach service business.
› Verified 7 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 7.33 | 14.46 |
Percentage of long-stay residents who lose too much weight | 5.64 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 46.53 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.19 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.44 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0.7 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.16 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.68 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 9.04 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.83 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.55 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 13.2 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.08 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 4.56 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.26 | 95.98 |
Percentage of short-stay residents who made improvements in function | 81.33 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 74.71 | 82.93 |
News Archive
Boehringer Ingelheim today announced that the New Drug Application (NDA) for its investigational oncology compound afatinib has been accepted for filing and granted Priority Review by the U.S. Food and Drug Administration (FDA).
The Royal Melbourne Hospital has performed the world's first implant of cultured specialist stem cells into an orthopaedic patient who suffered a broken femur nine months ago which failed to heal.
Molecular classification of the four distinct subtypes of gastric cancer could potentially shape tailored treatment options by helping to predict survival outcomes and patients' response to chemotherapy.
In a survey of more than 200 unique hospitals from across the US, nearly half of healthcare organizations (or 47.3 percent) believe their organization is already compliant with federal privacy laws such as ARRA HITECH and HIPAA and is audit ready.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has completed the previously announced acquisition of MemorialCare Health System's laboratory outreach service business.
› Verified 7 days ago
Eastview Rehabilitation & Healthcare Center Location: 7755 Fourth Avenue South, Birmingham, Alabama 35206 Phone: (205) 833-0146 | |
Northway Health And Rehabilitation, Llc Location: 1424 North 25th Street, Birmingham, Alabama 35234 Phone: (205) 328-5870 | |
North Hill Nursing And Rehabilitation Ctr, Llc Location: 200 North Pine Hill Road, Birmingham, Alabama 35217 Phone: (205) 849-2352 | |
South Health And Rehabilitation, Llc Location: 1220 South 17th Street, Birmingham, Alabama 35205 Phone: (205) 933-2180 | |
Civic Center Health And Rehabilitation, Llc Location: 1201 22nd Street North, Birmingham, Alabama 35234 Phone: (205) 251-5271 |